NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Teva Pharmaceutical Industrie
s Limited page 5

 

Note 9 - Taxes on Income:

a. The Company and its Israeli subsidiaries:

1) Tax benefits under the Law for the Encouragement of Capital Investments, 1959 (hereafter - the law)

Expansion projects of the Company and certain of its subsidiaries have been granted the status of "approved enterprise" under the law. Since the Company is over 49% foreign-owned, income derived from these enterprises during a period of 10 years from the year in which these enterprises first realize taxable income, provided the maximum period to which it is restricted by law has not elapsed, is subject to corporate tax at the rate of 20%.

Additional expansion projects of the Company and of certain subsidiaries were granted "approved enterprise" status, for which the companies elected to apply for alternative tax benefits - waiver of grants in return for tax exemption; such tax exemption is for a limited period, having regard to the area in which the enterprises are located. During the remainder of the benefits period (until expiration of 10 years), corporate tax of 20% as above is to apply. The periods of tax benefits in respect of approved enterprises entitled to the said benefits commenced in 1991-1998. Final approvals in respect of certain expansion programs have not yet been received. In the event of the distribution of dividends from the said tax-exempt income, the amount distributed will be subject to 20% tax (see also note 1i(2)).

The law also allows accelerated depreciation on buildings, machinery and equipment used by the "approved enterprise" during five tax years.

The entitlement to the above benefits is conditional upon the companies' fulfilling the conditions stipulated by the law, regulations published thereunder and the instruments of approval for the specific investments in approved enterprises. In the event of failure to comply with these conditions, the benefits may be cancelled and the companies may be required to refund the amount of the benefits, in whole or in part, with the addition of linkage differences and interest.

2) Measurement of results for tax purposes

Results for tax purposes are measured on the real basis - adjusted for the increase in the Israeli CPI. As explained in note 1a(2), the financial statements are presented in dollars. The difference between the change in the Israeli CPI and the NIS/U.S. dollar exchange rate - both on annual and cumulative bases - causes a difference between taxable income and income reflected in these financial statements expressed in dollars.

3) Tax benefits under the Law for the Encouragement of Industry (Taxation), 1969

The Company and certain of its subsidiaries are "industrial companies" under the above law. In accordance with this law and certain regulations, the companies are entitled to claim depreciation at increased rates. Under this law, the Company files consolidated tax returns with certain subsidiaries.

4) Tax rates applicable in Israel to income from other sources

Income not eligible for "approved enterprise" benefits mentioned in (1) above is taxed at the regular rate of 36%.

b. Deferred income taxes:

1) The composition of the deferred taxes and the changes therein in 1998 and 1997 are as follows:

  In respect of balance sheet items  
  Depreciable
fixed
assets
Inventories Provisions
for employee
rights upon
retirement and
vacation pay
Unrealized
income from
intercompany
sales
Other - net In respect
of net
operating
loss
carryforwards*
Total
  U.S. $ in thousands
 Balance at January 1, 1997 23,923 (36) (3,967) (4,965) (2,555) (18,256) (5,856)
 Changes in 1997: 6,666 1,084 1,339 3,018 7,381 1,264 20,752
 Amounts carried to income              
 Other - net** (557)       (107) 474 (190)
 Balance at December 31, 1997 30,032 1,048 (2,628) (1,947) 4,719 (16,518) 14,706
 Changes in 1998:              
  Amounts carried to income 9,437 716 47 (2,598) (8,331) 3,968 3,239
  Other - net** (769) (83) (791)   782 (514) (1,375)
 Balance at December 31, 1998 38,700 1,681 (3,372) (4,545) (2,830) (13,064) 16,570


* Most can be utilized with no expiration date.

** These changes relate to differences resulting from translation of the financial statements of subsidiaries drawn up in non-dollar currencies and to deferred taxes of a subsidiary consolidated for the first time in 1998, upon acquisition.

2) The deferred taxes are presented in the balance sheets as follows:

  December 31
  1998 1997
  U.S. $ in thousands
  Among current liabilities
  (current assets)
(16,602) 955
  As a non-current liability 33,172 13,751
  16,570 14,706


c. Income before taxes on income is composed as follows:

  Year ended December 31
  1998 1997 1996
  U.S. $ in thousands
  The Company and subsidiaries
  in Israel
52,488 115,682 76,844
  Subsidiaries outside Israel 46,357 23,934 16,480
  98,845 139,616 93,324


d. Taxes on income included in the income statements:

1) As follows:

  Year ended December 31
  1998 1997 1996
  U.S. $ in thousands
  Current:      
  In Israel 15,810 18,633 18,259
  Outside Israel 11,839 (658)* 11,320
  27,649 17,975 29,579
  Deferred:      
  In Israel 59 10,514 (6,750)
  Outside Israel 3,180 10,238* (1,931)
  3,239 20,752 (8,681)
  30,888 38,727 20,898


* Net of a tax benefit of approximately $ 7 million, resulting mainly from a change in the tax laws in the United States in 1997 making certain expenses deductible on the accrual basis; previously these expenses were deductible on a cash basis. This change did not affect the total tax expenses of the group, since an amount similar to the amount of the reduction in current taxes has been charged to deferred taxes.

2) A reconciliation of the theoretical tax expense, assuming all income is taxed at the regular rates applicable to income of companies in Israel (see a(4) above) and the actual tax expense, is as follows:

  Year ended December 31
  1998 1997 1996
  U.S. $ in thousands
  Income before taxes on income, per      
  consolidated statements of income 98,845 139,616 93,324
  Theoretical tax expense 35,584 50,262 33,597
  Tax benefit arising from reduced tax rate as
an "approved enterprise"
(4,808) (11,377) (13,358)
  30,776 38,885 20,239
 Increase (decrease) in tax arising from different
tax rates applicable to non-Israeli subsidiaries
(5,352) (9,345) (1,175)
  Increase (decrease) in taxes resulting from
permanent differences:
     
  Tax exempt income (1,432) (632) (2,371)
  Disallowable deductions 3,348 10,242 5,931
  Difference between income reported for tax      
  purposes and income for financial reporting      
 purposes (see also a(2) above) - net 846 1,470 (1,007)
 Sundry - net 2,702 (1,893) (719)
  Taxes on income in the consolidated      
 statements of income 30,888 38,727 20,898
 Effective tax rate 31% 28% 22%


e. Tax assessments

The Company has received final tax assessments through tax year 1990. The subsidiaries have received final tax assessments through tax years 1990-1994.

The Company has received tax assessments for the tax years 1992 and 1993, under which it is required to pay $ 2.2 million (including linkage differences and interest). The Company disputes the position of the tax authorities and is contesting these assessments. The tax authorities' response to the Company's appeal has not yet been received. The Company has not made any provision for this matter.

 

Click here for the next page